Quirong, Ana Jane T.
HRN: 17-78-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2024
CEFUROXIME 500MG (TAB)
12/02/2024
12/08/2024
PO
1 Tab
Bid
PROM; S/p Nsvd
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes